AirSculpt Technologies, Inc. (AIRS)
USD 1.78
(-2.47%)
USD 1.78
(-2.47%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 121.9 Million USD | 5.32% |
| 2022 | 106.01 Million USD | 19.41% |
| 2021 | 88.77 Million USD | 125.93% |
| 2020 | 39.29 Million USD | 52.61% |
| 2019 | 25.74 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 29.29 Million USD | 9.41% |
| 2024 Q1 | 26.77 Million USD | -0.72% |
| 2023 Q2 | 35.75 Million USD | 28.62% |
| 2023 Q1 | 27.79 Million USD | 11.34% |
| 2023 FY | 111.65 Million USD | 5.32% |
| 2023 Q4 | 26.96 Million USD | -5.77% |
| 2023 Q3 | 28.61 Million USD | -19.95% |
| 2022 Q1 | 24.88 Million USD | 1.63% |
| 2022 Q3 | 24 Million USD | -25.37% |
| 2022 Q2 | 32.16 Million USD | 29.26% |
| 2022 FY | 106.01 Million USD | 19.41% |
| 2022 Q4 | 24.96 Million USD | 4.0% |
| 2021 Q2 | 23.74 Million USD | 36.81% |
| 2021 FY | 88.77 Million USD | 125.93% |
| 2021 Q4 | 24.48 Million USD | 5.34% |
| 2021 Q3 | 23.24 Million USD | -2.12% |
| 2021 Q1 | 17.35 Million USD | 14.0% |
| 2020 Q4 | 15.22 Million USD | 37.42% |
| 2020 Q3 | 11.07 Million USD | 54.92% |
| 2020 Q2 | 7.15 Million USD | 0.0% |
| 2020 Q1 | 7.15 Million USD | 0.0% |
| 2020 FY | 39.29 Million USD | 52.61% |
| 2019 FY | 25.74 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 82.141% |
| Addus HomeCare Corporation | 339.87 Million USD | 64.133% |
| Amedisys, Inc. | 457.07 Million USD | 73.329% |
| American Oncology Network, Inc. | 66.05 Million USD | -84.545% |
| Astrana Health, Inc. | 214.95 Million USD | 43.289% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 79.527% |
| IMAC Holdings, Inc. | 3.84 Million USD | -3067.501% |
| biote Corp. | 127.48 Million USD | 4.375% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -432.304% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 71.785% |
| COMPASS Pathways plc | -242.93 Thousand USD | 50279.47% |
| DocGo Inc. | 178.95 Million USD | 31.878% |
| The Ensign Group, Inc. | 590.75 Million USD | 79.365% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 51.519% |
| InnovAge Holding Corp. | 132.06 Million USD | 7.692% |
| Assure Holdings Corp. | -2.19 Million USD | 5656.29% |
| The Joint Corp. | 107.14 Million USD | -13.771% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 59.647% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 11475.502% |
| ModivCare Inc. | 446.95 Million USD | 72.725% |
| NewGenIvf Group Limited | 1.68 Million USD | -7148.548% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -2361.377% |
| Option Care Health, Inc. | 981.22 Million USD | 87.576% |
| P3 Health Partners Inc. | 31.63 Million USD | -285.349% |
| P3 Health Partners Inc. | 31.63 Million USD | -285.349% |
| The Pennant Group, Inc. | 61.9 Million USD | -96.92% |
| Surgery Partners, Inc. | 529.4 Million USD | 76.973% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -8534.11% |
| Talkspace, Inc. | 74.38 Million USD | -63.895% |
| Talkspace, Inc. | 74.38 Million USD | -63.895% |
| The Oncology Institute, Inc. | 59.57 Million USD | -104.631% |
| The Oncology Institute, Inc. | 59.57 Million USD | -104.631% |